In a non-randomized trial, a remote continuous care model delivering a very low carbohydrate, high fat, non-calorie-restricted diet was effective at lowering A1C, promoting weight loss, and reducing the use of glucose-lowering medications (including insulin) in patients with T2D [14, 15]. This evidence concerns the gene INS and type 2 diabetes mellitus.